The purpose of the study is to test the safety, tolerability, immunogenicity and clinical efficacy of the combination treatment AllQbG10 in patients with rhino-conjunctivitis and asthma due to house dust mite allergy in a single-center, open-label setting.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
21
Immunomodulator CYT003-QbG10 in combination with commercial house dust mite extract as used for routine SIT
University Hospital Zurich, Department of Dermatology
Zurich, Canton of Zurich, Switzerland
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.